Korean J Urol.  1991 Oct;32(5):744-749.

Isolation of ureaplasma urealyticum from patient with genitourinary tract infection attending urologic clinic

Affiliations
  • 1Department of Urology, Kosin Medical College, Pusan, Korea.

Abstract

Since the discovery of U. urealyticum in human. the etiologic role of this microbe to urogenital tract infection has been investigated. U. urealyticum is one of the etiologic agents for such infections of human urogenital tract as nongonococcal urethritis. prostatitis. cystitis. infertility. interauterine infection, in which standard bacteriologic investigation had failed to indicate bacterial infection. We studied the occurrence of U. urealyticum in urogenital tract of persons in the district of Pusan. From March, 1990 to June. 1990, 290 heterosexual patients and 102 normal control were cultured for U. urealyticum. The results were as follows : l. Overall incidence of this organism was 19.3%, 32.2% from urethral swab and 10.5% from urine, which was lower than that of control group. 2. The incidence of this organism in Females (32.7%) was generally higher than that in males ( 16.6%). 3. This microbe was well detected in middle age person. 4. This microbe was higher detected in specimen from urethral swab (32.2%) than urine (10.5%). 5. The isolation ratio in local private clinics was lower than that in Kosin medical center. 6. Erythromycin had the best sensitivity against U. urealyticum followed by streptomycin. But tetracycline and oxytetacycline were highly resistant to this organism.

Keyword

ureaplasma urealyticum; mycoplasma

MeSH Terms

Bacterial Infections
Busan
Cystitis
Erythromycin
Female
Heterosexuality
Humans
Incidence
Infertility
Male
Middle Aged
Mycoplasma
Prostatitis
Streptomycin
Tetracycline
Ureaplasma urealyticum*
Ureaplasma*
Urethritis
Erythromycin
Streptomycin
Tetracycline
Full Text Links
  • KJU
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr